Mechanotherapy in oncology: Targeting nuclear mechanics and mechanotransduction
Advanced Drug Delivery Reviews, ISSN: 0169-409X, Vol: 194, Page: 114722
2023
- 17Citations
- 19Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations17
- Citation Indexes17
- 17
- CrossRef1
- Captures19
- Readers19
- 19
Review Description
Mechanotherapy is proposed as a new option for cancer treatment. Increasing evidence suggests that characteristic differences are present in the nuclear mechanics and mechanotransduction of cancer cells compared with those of normal cells. Recent advances in understanding nuclear mechanics and mechanotransduction provide not only further insights into the process of malignant transformation but also useful references for developing new therapeutic approaches. Herein, we present an overview of the alterations of nuclear mechanics and mechanotransduction in cancer cells and highlight their implications in cancer mechanotherapy.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0169409X23000376; http://dx.doi.org/10.1016/j.addr.2023.114722; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85148011337&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/36738968; https://linkinghub.elsevier.com/retrieve/pii/S0169409X23000376; https://dx.doi.org/10.1016/j.addr.2023.114722
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know